<DOC>
	<DOCNO>NCT01293045</DOCNO>
	<brief_summary>- Preliminary scientific study , animal human suggest oral consumption hydrolyze collagen act bone remodel process stimulate activity osteoblasts responsible bone formation improve bone mineral density biomechanical resistance long bone . - The objective clinical research measure change biomarkers bone turnover postmenopausal healthy woman , osteoporotic , response consumption hydrolyze collagen three month . - For , propose measure blood urinary marker formation bone resorption consumption , 45 90 day daily consumption 10 g hydrolyze collagen .</brief_summary>
	<brief_title>Biological Bone Markers Hydrolyzed Collagen Supplement Menopausal Healthy Women</brief_title>
	<detailed_description />
	<mesh_term>Osteoporosis</mesh_term>
	<criteria>Healthy woman Aged 55 65 year Primary secondary amenorrhea least 5 year BMI â‰¥ 20 kg/m2 &lt; 27 kg/m2 DXA &gt; 2.5 SD No history fragility fracture bone Not guardianship Not hormone replacement osteoporotic therapy Covered Social Security Negative serology hepatitis B/C HIV Written inform consent form sign . Bone density &lt; 2.5 SD ( standard deviation ) Endocrine disease No history fragility fracture bone Dietary disorder ( anorexia , bulimia ) Hormone replacement therapy Inclusion another clinical study Subjects receive 4,500 Euros last 12 month ( include present study ) Subjects present risk noncompliance opinion recruit doctor .</criteria>
	<gender>Female</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>Osteoporosis</keyword>
	<keyword>Postmenopausal woman</keyword>
	<keyword>Functional food</keyword>
	<keyword>Hydrolysed collagen</keyword>
	<keyword>Bone metabolism</keyword>
	<keyword>Bone marker resorption</keyword>
	<keyword>Bone marker formation</keyword>
</DOC>